Vik Chopra
Stock Analyst at Wells Fargo
(3.76)
# 664
Out of 5,150 analysts
68
Total ratings
55.17%
Success rate
9.48%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $86 → $83 | $70.40 | +17.90% | 6 | Feb 27, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $13 → $12 | $10.39 | +15.50% | 3 | Feb 27, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $12 → $13 | $13.44 | -3.27% | 5 | Feb 27, 2026 | |
| GMED Globus Medical | Maintains: Overweight | $98 → $104 | $90.46 | +14.97% | 12 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $76 → $87 | $80.58 | +7.97% | 4 | Feb 25, 2026 | |
| MASI Masimo | Downgrades: Equal-Weight | $190 → $180 | $175.37 | +2.64% | 11 | Feb 18, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $21 → $26 | $28.43 | -8.55% | 4 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $181 → $200 | $182.16 | +9.79% | 5 | Feb 5, 2026 | |
| CNMD CONMED | Maintains: Equal-Weight | $41 → $42 | $42.99 | -2.30% | 7 | Jan 29, 2026 | |
| ENOV Enovis | Maintains: Overweight | $41 → $42 | $25.79 | +62.85% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $16 | $13.95 | +14.70% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $13.00 | +23.08% | 2 | Oct 16, 2025 |
Solventum
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $86 → $83
Current: $70.40
Upside: +17.90%
Integra LifeSciences Holdings
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $13 → $12
Current: $10.39
Upside: +15.50%
DENTSPLY SIRONA
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $13.44
Upside: -3.27%
Globus Medical
Feb 26, 2026
Maintains: Overweight
Price Target: $98 → $104
Current: $90.46
Upside: +14.97%
Henry Schein
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $76 → $87
Current: $80.58
Upside: +7.97%
Masimo
Feb 18, 2026
Downgrades: Equal-Weight
Price Target: $190 → $180
Current: $175.37
Upside: +2.64%
Envista Holdings
Feb 6, 2026
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $28.43
Upside: -8.55%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $181 → $200
Current: $182.16
Upside: +9.79%
CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41 → $42
Current: $42.99
Upside: -2.30%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $25.79
Upside: +62.85%
Nov 5, 2025
Maintains: Overweight
Price Target: $15 → $16
Current: $13.95
Upside: +14.70%
Oct 16, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $13.00
Upside: +23.08%